Go Pro

Mraz Amerine & Associates Inc. Cuts Holdings in DuPont de Nemours, Inc. $DD

DuPont de Nemours logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Mraz Amerine & Associates cut its DuPont stake by 66.5% in the second quarter, selling 7,993 shares and retaining 4,025 shares valued at approximately $546,000.
  • Analyst sentiment remains broadly positive, with 12 Buy ratings, four Holds and one Sell; the stock carries a “Moderate Buy” consensus and an average price target of $166.60.
  • DuPont exceeded quarterly earnings expectations, reporting $1.88 in adjusted EPS on $1.82 billion in revenue, while its shares recently traded at $131.46. The company’s annualized dividend is $2.40 per share, implying a 1.8% yield.
  • MarketBeat previews the top five stocks to own by October 1st.

Mraz Amerine & Associates Inc. decreased its position in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 66.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,025 shares of the basic materials company's stock after selling 7,993 shares during the period. Mraz Amerine & Associates Inc.'s holdings in DuPont de Nemours were worth $546,000 as of its most recent filing with the SEC.

Other hedge funds have also recently modified their holdings of the company. Palisade Asset Management LLC purchased a new stake in shares of DuPont de Nemours during the third quarter valued at approximately $26,000. Imprint Wealth LLC purchased a new position in DuPont de Nemours in the third quarter worth $27,000. Basepoint Wealth LLC bought a new position in DuPont de Nemours in the 4th quarter valued at $28,000. Nalls Sherbakoff Group LLC bought a new position in DuPont de Nemours in the 4th quarter valued at $29,000. Finally, Measured Wealth Private Client Group LLC purchased a new stake in shares of DuPont de Nemours during the 3rd quarter valued at $30,000. Institutional investors own 73.96% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on DD. Citigroup lifted their target price on DuPont de Nemours from $168.00 to $170.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Weiss Ratings restated a "sell (d+)" rating on shares of DuPont de Nemours in a research report on Monday, August 3rd. JPMorgan Chase & Co. raised their price objective on shares of DuPont de Nemours from $171.00 to $172.00 and gave the stock an "overweight" rating in a report on Monday, August 10th. The Goldman Sachs Group boosted their target price on shares of DuPont de Nemours from $53.00 to $159.00 and gave the company a "neutral" rating in a research note on Thursday, June 25th. Finally, Zacks Research downgraded shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 17th. Twelve research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $166.60.

View Our Latest Research Report on DuPont de Nemours

DuPont de Nemours Stock Performance

DuPont de Nemours stock traded down $0.13 during midday trading on Tuesday, reaching $131.46. The stock had a trading volume of 1,212,074 shares, compared to its average volume of 1,427,403. The firm has a market capitalization of $17.75 billion, a PE ratio of 292.20, a P/E/G ratio of 1.20 and a beta of 1.06. DuPont de Nemours, Inc. has a 12 month low of $92.49 and a 12 month high of $157.98. The company has a quick ratio of 1.82, a current ratio of 2.43 and a debt-to-equity ratio of 0.23. The firm's 50-day moving average price is $138.34 and its 200 day moving average price is $140.50.

DuPont de Nemours (NYSE:DD - Get Free Report) last issued its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.76 by $0.12. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter last year, the business earned $1.12 earnings per share. The company's quarterly revenue was up 4.0% on a year-over-year basis. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, research analysts predict that DuPont de Nemours, Inc. will post 7.27 earnings per share for the current fiscal year.

DuPont de Nemours Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.40 dividend on an annualized basis and a yield of 1.8%. DuPont de Nemours's payout ratio is presently 533.33%.

About DuPont de Nemours

(Free Report)

DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

See Also

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DuPont de Nemours Right Now?

Before you consider DuPont de Nemours, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.

While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines